Tristan Xerri

Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Struggling Saints face tough test against surging Rams in key NFC matchup
  • UK PM Starmer refuses to rule out tax hikes amid budget deficit, sparking debate within Labour party.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Struggling Saints face tough test against surging Rams in key NFC matchup
  • UK PM Starmer refuses to rule out tax hikes amid budget deficit, sparking debate within Labour party.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Tristan Xerri